These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 27495956)
1. Towards Improving the Transfer of Care of Kidney Transplant Recipients. Gill JS; Wright AJ; Delmonico FL; Newell KA Am J Transplant; 2017 Jan; 17(1):54-59. PubMed ID: 27495956 [TBL] [Abstract][Full Text] [Related]
2. Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help? Nerini E; Bruno F; Citterio F; Schena FP J Nephrol; 2016 Oct; 29(5):627-36. PubMed ID: 26885659 [TBL] [Abstract][Full Text] [Related]
3. Comparison of a home-based (multi) systemic intervention to promoting Medication AdheRence and Self-management among kidney transplant recipients with care-as-usual: the MARS randomized controlled trial protocol. Beck DK; Tielen M; Rechards M; Timman R; Boonstra C; Versteegh J; van de Wetering J; Zietse R; van Gelder T; Weimar W; van Saase J; van Busschbach J; Massey EK BMC Nephrol; 2020 Aug; 21(1):374. PubMed ID: 32859157 [TBL] [Abstract][Full Text] [Related]
4. Factors that determine self-reported immunosuppressant adherence in kidney transplant recipients: a correlational study. Weng LC; Yang YC; Huang HL; Chiang YJ; Tsai YH J Adv Nurs; 2017 Jan; 73(1):228-239. PubMed ID: 27532342 [TBL] [Abstract][Full Text] [Related]
5. Describing Predictors Of Regimen Nonadherence Among Kidney Recipients Using Multiple Measures. Balakrishnan A; Bailey S; Mroczek D; Serper M; Ladner D; Wolf M Prog Transplant; 2022 Sep; 32(3):226-232. PubMed ID: 35686344 [No Abstract] [Full Text] [Related]
6. Efficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open-label, noninferiority study. Harland RC; Klintmalm G; Jensik S; Yang H; Bromberg J; Holman J; Kumar MSA; Santos V; Larson TJ; Wang X Am J Transplant; 2020 Jan; 20(1):159-171. PubMed ID: 31509331 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and correlates of medication non-adherence among kidney transplant recipients more than 6 months post-transplant: a cross-sectional study. Weng FL; Chandwani S; Kurtyka KM; Zacker C; Chisholm-Burns MA; Demissie K BMC Nephrol; 2013 Dec; 14():261. PubMed ID: 24289809 [TBL] [Abstract][Full Text] [Related]
8. The transplant team's support of kidney transplant recipients to take their prescribed medications: a collective responsibility. Williams A; Low JK; Manias E; Crawford K J Clin Nurs; 2016 Aug; 25(15-16):2251-61. PubMed ID: 27264024 [TBL] [Abstract][Full Text] [Related]
9. Improving medication adherence and outcomes in adult kidney transplant patients using a personal systems approach: SystemCHANGE™ results of the MAGIC randomized clinical trial. Russell CL; Hathaway D; Remy LM; Aholt D; Clark D; Miller C; Ashbaugh C; Wakefield M; Ye S; Staggs VS; Ellis RJ; Goggin K Am J Transplant; 2020 Jan; 20(1):125-136. PubMed ID: 31291507 [TBL] [Abstract][Full Text] [Related]
10. Time-in-a-bottle (TIAB): a longitudinal, correlational study of patterns, potential predictors, and outcomes of immunosuppressive medication adherence in adult kidney transplant recipients. Russell CL; Ashbaugh C; Peace L; Cetingok M; Hamburger KQ; Owens S; Coffey D; Webb AW; Hathaway D; Winsett RP; Madsen R; Wakefield MR Clin Transplant; 2013; 27(5):E580-90. PubMed ID: 24093614 [TBL] [Abstract][Full Text] [Related]
11. The analysis of immunosuppressant therapy adherence, depression, anxiety, and stress in kidney transplant recipients in the post-transplantation period. Uyar B Transpl Immunol; 2022 Dec; 75():101686. PubMed ID: 35961441 [TBL] [Abstract][Full Text] [Related]
12. A Gap Analysis Assessing the Perceptions of Primary Care Physicians in the Management of Kidney Recipients After Transplantation. Famure O; Caballero MN; Li A; Tang R; Chen PX; Ashwin M; Adcock L; Schiff J; Kim SJ Prog Transplant; 2019 Dec; 29(4):309-315. PubMed ID: 31510872 [TBL] [Abstract][Full Text] [Related]
13. Determining the effect of immunosuppressant adherence on graft failure risk among renal transplant recipients. Spivey CA; Chisholm-Burns MA; Damadzadeh B; Billheimer D Clin Transplant; 2014 Jan; 28(1):96-104. PubMed ID: 24329814 [TBL] [Abstract][Full Text] [Related]
14. Economic Evaluation of Extending Medicare Immunosuppressive Drug Coverage for Kidney Transplant Recipients in the Current Era. Kadatz M; Gill JS; Gill J; Formica RN; Klarenbach S J Am Soc Nephrol; 2020 Jan; 31(1):218-228. PubMed ID: 31704739 [TBL] [Abstract][Full Text] [Related]
15. Nephrologists' management of patient medications in kidney transplantation: results of an online survey. Crawford K; Low JK; Manias E; Walker R; Toussaint ND; Mulley W; Dooley M; Ierino FL; Hughes P; Goodman DJ; Williams A J Eval Clin Pract; 2015 Oct; 21(5):879-85. PubMed ID: 26371625 [TBL] [Abstract][Full Text] [Related]
16. De Novo Belatacept in a Human Immunodeficiency Virus-Positive Kidney Transplant Recipient. Cohen EA; Mulligan D; Kulkarni S; Tichy EM Am J Transplant; 2016 Sep; 16(9):2753-7. PubMed ID: 27137752 [TBL] [Abstract][Full Text] [Related]
17. A Medication Adherence Promotion System to Reduce Late Kidney Allograft Rejection: A Quality Improvement Study. Hooper DK; Varnell CD; Rich K; Carle A; Huber J; Mostajabi F; Dahale D; Pai ALH; Goebel J; Modi AC Am J Kidney Dis; 2022 Mar; 79(3):335-346. PubMed ID: 34352285 [TBL] [Abstract][Full Text] [Related]
18. Exploring Transplant Medication-Taking Behaviours in Older Adult Kidney Transplant Recipients: A Qualitative Study of Semi-Structured Interviews. Cossart AR; Staatz CE; Isbel NM; Campbell SB; Cottrell WN Drugs Aging; 2022 Nov; 39(11):887-898. PubMed ID: 36175739 [TBL] [Abstract][Full Text] [Related]